Ocugen Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
/ 
Frequently asked questions
To buy Ocugen Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Ocugen Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Ocugen Inc. is OCGN:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Ocugen Inc. has its primary listing on NASDAQ. You can trade Ocugen Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Ocugen Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Ocugen Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Ocugen Inc..